Key result
SCN5A allelic expression imbalance occurred in 50% of heterozygous African-American infants, but the proportion with elevated variant expression did not differ significantly between SIDS cases and controls.
Why the study?
Does SCN5A allelic expression imbalance correlate with the risk of sudden infant death syndrome (SIDS) in African-American infants heterozygous for p.Ser1103Tyr?
Case-Control (n=26)
Yes
Does SCN5A allelic expression imbalance correlate with the risk of sudden infant death syndrome (SIDS) in African-American infants heterozygous for p.Ser1103Tyr?
SCN5A allelic expression imbalance occurs in African-Americans heterozygous for p.Ser1103Tyr, but it does not appear to be a marker for SIDS risk.
Answers are grounded in this paper and cite their sources.
SCN5A allelic expression imbalance should not guide SIDS risk assessment in African-American heterozygotes; leaves open whether other modifiers influence variant expression.
BACKGROUND: Heterozygous and homozygous carriers of SCN5A-p.Ser1103Tyr, a common genetic variant with functional effects among African-Americans, have an increased risk of sudden death. We hypothesized that some heterozygous carriers may have unequal expression of wild-type and variant alleles and secondarily that predominance of the variant gene copy could further increase risk for sudden death in this population. METHODS: We quantified allele-specific expression of SCN5A-p.Ser1103Tyr by real-time reverse-transcription polymerase chain reaction (RT-PCR) in heart tissue from heterozygous African-American infants, who died from sudden infant death syndrome (SIDS) or from other causes, to test for allelic expression imbalance. RESULTS: We observed significant allelic expression imbalance in 13 of 26 (50%) African-American infant hearts heterozygous for SCN5A-p.Ser1103Tyr, and a significant (p < 0.0001) bimodal distribution of log2 allelic expression ratios. However, there were no significant differences in the mean log2 allelic expression ratios in hearts of infants dying from SIDS as compared to infants dying from other causes and no significant difference in the proportion of cases with greater expression of the variant allele. CONCLUSIONS: Our data provide evidence that SCN5A allelic expression imbalance occurs in African-Americans heterozygous for p.Ser1103Tyr, but this phenomenon alone does not appear to be a marker for risk of SIDS.
No takes yet. Share an insight, caveat, or question.
Killen et al. (2010) conducted a case-control in Sudden Infant Death Syndrome (n=26). SIDS cases vs. Non-SIDS infant death controls was evaluated on Elevated variant allele expression (p=>0.8). SCN5A allelic expression imbalance occurred in 50% of heterozygous African-American infants, but the proportion with elevated variant expression did not differ significantly between SIDS cases and controls.
Synapse has enriched 10 related papers. Consider them for comparative context: